Search Results - "NOORY, Carol"

Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate by BRAVE, Michael, GOODMAN, Vicki, MEN, Angela, NOORY, Carol, RAMCHANDANI, Roshni, KENNA, Leslie, BOOTH, Brian, GOBBURU, Joga, XIAOPING JIANG, SRIDHARA, Rajeshwari, JUSTICE, Robert, PAZDUR, Richard, KAMINSKAS, Edvardas, FARRELL, Ann, TIMMER, William, POPE, Sarah, HARAPANHALLI, Ravi, SABER, Haleh, MORSE, David, BULLOCK, Julie

“…Purpose: On June 28, 2006, the U.S. Food and Drug Administration approved dasatinib (Sprycel; Bristol-Myers Squibb), a new small-molecule inhibitor of multiple…”
Get full text

In vitro dissolution of sparingly water-soluble drug dosage forms by Shah, Vinod P., Noory, Assad, Noory, Carol, McCullough, Bruce, Clarke, Sanford, Everett, Richard, Naviasky, Helen, Srinivasan, B.N., Fortman, Don, Skelly, Jerome P.

“…An in vitro procedure for the evaluation of sparingly water-soluble drug products has been developed and tested. The data on several sparingly water-soluble…”
Get full text

Rethinking the Use of Water as a Dissolution Medium by Noory, Carol, Tran, Nhan, Ouderkirk, Larry, Brown, Sara, Perry, Jesse, Lopez, José, Colon, Miquel, Faberlle, Marisol, Henry, Kermit, Rorberg, Julie, Nasir Ali, Syed, Shah, Vinod

Get full text

Steps for Development of a Dissolution Test for Sparingly Water-Soluble Drug Products by Noory, Carol, Tran, Nhan, Ouderkirk, Larry, Shah, Vinod

Get full text